tiprankstipranks
Lexicon Pharmaceuticals (LXRX)
NASDAQ:LXRX
US Market
LXRX
Lexicon Pharmaceuticals
RESEARCH TOOLSreports
Want to see LXRX full AI Analyst Report?

Lexicon Pharmaceuticals (LXRX) Income Statement

1,798 Followers

Lexicon Pharmaceuticals Income Statement

Last quarter (Q4 2025), Lexicon Pharmaceuticals's total revenue was $5.49M, a decrease of -79.31% from the same quarter last year. In Q4, Lexicon Pharmaceuticals's net income was $-15.53M. See Lexicon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 49.80M$ 31.08M$ 1.20M$ 139.00K$ 298.00K
Gross Profit
$ 49.53M$ 30.46M$ -57.77M$ -52.38M$ -54.75M
Operating Expenses
$ 98.44M$ 227.58M$ 113.98M$ 48.38M$ 32.34M
Depreciation and Amortization
$ 621.00K$ 534.00K$ 554.00K$ 427.00K$ 292.00K
EBITDA
$ -48.29M$ -184.29M$ -169.76M$ -100.03M$ -86.80M
Operating Income
$ -48.91M$ -197.12M$ -171.75M$ -100.76M$ -87.09M
Other Income/Expenses
$ -1.43M$ -3.29M$ -5.37M$ -1.18M$ -668.00K
Pretax Income
$ -50.34M$ -200.40M$ -177.12M$ -101.94M$ -87.76M
Net Income
$ -50.34M$ -200.40M$ -177.12M$ -101.94M$ -87.76M
Per Share Metrics
Basic EPS
$ -0.14$ -0.63$ -0.80$ -0.62$ -0.61
Diluted EPS
$ -0.14$ -0.63$ -0.80$ -0.62$ -0.61
Weighted Average Shares Outstanding
 363.05M 320.03M 221.13M 165.73M 145.65M
Weighted Average Shares Outstanding (Diluted)
 363.05M 320.03M 221.13M 165.73M 145.65M
Currency in USD

Lexicon Pharmaceuticals Earnings and Revenue History